These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27076309)

  • 1. Vaccine Design: Replication-Defective Adenovirus Vectors.
    Zhou X; Xiang Z; Ertl HCJ
    Methods Mol Biol; 2016; 1404():329-349. PubMed ID: 27076309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplified and persistent immune responses generated by single-cycle replicating adenovirus vaccines.
    Crosby CM; Nehete P; Sastry KJ; Barry MA
    J Virol; 2015 Jan; 89(1):669-75. PubMed ID: 25355873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved adenovirus packaging cell lines to support the growth of replication-defective gene-delivery vectors.
    Amalfitano A; Begy CR; Chamberlain JS
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3352-6. PubMed ID: 8622940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IIIa deleted adenovirus as a single-cycle genome replicating vector.
    Crosby CM; Barry MA
    Virology; 2014 Aug; 462-463():158-65. PubMed ID: 24996029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new type of adenovirus vector that utilizes homologous recombination to achieve tumor-specific replication.
    Bernt K; Liang M; Ye X; Ni S; Li ZY; Ye SL; Hu F; Lieber A
    J Virol; 2002 Nov; 76(21):10994-1002. PubMed ID: 12368342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coli.
    Hoffmann D; Wildner O
    BMC Biotechnol; 2006 Aug; 6():36. PubMed ID: 16887042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease-deleted adenovirus vectors and complementing cell lines: potential applications of single-round replication mutants for vaccination and gene therapy.
    Oualikene W; Lamoureux L; Weber JM; Massie B
    Hum Gene Ther; 2000 Jun; 11(9):1341-53. PubMed ID: 10890743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lac-regulated system for generating adenovirus 5 vaccine vectors expressing cytolytic human immunodeficiency virus 1 genes.
    Zhao C; Crews CJ; Derdeyn CA; Blackwell JL
    J Virol Methods; 2009 Sep; 160(1-2):101-10. PubMed ID: 19409930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient mobilization of E1-deleted adenovirus type 5 vectors by wild-type adenoviruses of other serotypes.
    Rademaker HJ; El Hassan MAA; Versteeg GA; Rabelink MJWE; Hoeben RC
    J Gen Virol; 2002 Jun; 83(Pt 6):1311-1314. PubMed ID: 12029145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.
    Fallaux FJ; Bout A; van der Velde I; van den Wollenberg DJ; Hehir KM; Keegan J; Auger C; Cramer SJ; van Ormondt H; van der Eb AJ; Valerio D; Hoeben RC
    Hum Gene Ther; 1998 Sep; 9(13):1909-17. PubMed ID: 9741429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a high-capacity hybrid vector: packaging of recombinant adenoassociated virus replicative intermediates in adenovirus capsids overcomes the limited cloning capacity of adenoassociated virus vectors.
    Gonçalves MA; Pau MG; de Vries AA; Valerio D
    Virology; 2001 Sep; 288(2):236-46. PubMed ID: 11601895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning and Large-Scale Production of High-Capacity Adenoviral Vectors Based on the Human Adenovirus Type 5.
    Ehrke-Schulz E; Zhang W; Schiwon M; Bergmann T; Solanki M; Liu J; Boehme P; Leitner T; Ehrhardt A
    J Vis Exp; 2016 Jan; (107):e52894. PubMed ID: 26863087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-capacity adenoviral vectors circumvent the limitations of ΔE1 and ΔE1/ΔE3 adenovirus vectors to induce multispecific transgene product-directed CD8 T-cell responses.
    Kron MW; Engler T; Schmidt E; Schirmbeck R; Kochanek S; Kreppel F
    J Gene Med; 2011 Dec; 13(12):648-57. PubMed ID: 22095925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isogenic adenoviruses type 5 expressing or not expressing the E1A gene: efficiency as virus vectors in the vaccination of permissive and non-permissive species.
    Eloit M; Adam M
    J Gen Virol; 1995 Jul; 76 ( Pt 7)():1583-9. PubMed ID: 9049365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human adenovirus cloning vectors based on infectious bacterial plasmids.
    Ghosh-Choudhury G; Haj-Ahmad Y; Brinkley P; Rudy J; Graham FL
    Gene; 1986; 50(1-3):161-71. PubMed ID: 3472993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of CD8+ T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers.
    Pinto AR; Fitzgerald JC; Giles-Davis W; Gao GP; Wilson JM; Ertl HC
    J Immunol; 2003 Dec; 171(12):6774-9. PubMed ID: 14662882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. State-of-the-art human adenovirus vectorology for therapeutic approaches.
    Gao J; Mese K; Bunz O; Ehrhardt A
    FEBS Lett; 2019 Dec; 593(24):3609-3622. PubMed ID: 31758807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence.
    Hehir KM; Armentano D; Cardoza LM; Choquette TL; Berthelette PB; White GA; Couture LA; Everton MB; Keegan J; Martin JM; Pratt DA; Smith MP; Smith AE; Wadsworth SC
    J Virol; 1996 Dec; 70(12):8459-67. PubMed ID: 8970968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo.
    Lieber A; He CY; Kirillova I; Kay MA
    J Virol; 1996 Dec; 70(12):8944-60. PubMed ID: 8971024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of Replication-Competent Adenovirus Serotype 26 Vaccines by Vectorization.
    Maxfield LF; Abbink P; Stephenson KE; Borducchi EN; Ng'ang'a D; Kirilova MM; Paulino N; Boyd M; Shabram P; Ruan Q; Patel M; Barouch DH
    Clin Vaccine Immunol; 2015 Nov; 22(11):1166-75. PubMed ID: 26376928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.